Mark A. Keibler

2.6k total citations · 1 hit paper
14 papers, 1.6k citations indexed

About

Mark A. Keibler is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Mark A. Keibler has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Biochemistry. Recurrent topics in Mark A. Keibler's work include Cancer, Hypoxia, and Metabolism (9 papers), Metabolism, Diabetes, and Cancer (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Mark A. Keibler is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Metabolism, Diabetes, and Cancer (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Mark A. Keibler collaborates with scholars based in United States, Germany and Israel. Mark A. Keibler's co-authors include Gregory Stephanopoulos, Matthew G. Vander Heiden, Thomas M. Wasylenko, Benjamin A. Olenchock, Grant V. Bochicchio, Matthew B. Dowling, John R. Hess, Srinivasa R. Raghavan, Abhishek Jha and James P. O’Brien and has published in prestigious journals such as Nature, Nature Communications and Biomaterials.

In The Last Decade

Mark A. Keibler

13 papers receiving 1.6k citations

Hit Papers

Environment Impacts the Metabolic Dependencies of Ras-Dri... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Keibler United States 9 1.0k 811 281 163 143 14 1.6k
Jacinta Serpa Portugal 26 1.1k 1.0× 501 0.6× 319 1.1× 257 1.6× 268 1.9× 77 2.0k
Abhinav Achreja United States 15 1.5k 1.5× 1.1k 1.4× 452 1.6× 141 0.9× 122 0.9× 23 2.1k
Katharina Leithner Austria 25 887 0.9× 509 0.6× 270 1.0× 351 2.2× 306 2.1× 45 2.0k
Melanie Wergin Switzerland 16 1.3k 1.2× 1.2k 1.4× 317 1.1× 269 1.7× 86 0.6× 29 1.9k
Santina Quarta Italy 24 661 0.6× 355 0.4× 288 1.0× 112 0.7× 139 1.0× 64 1.5k
Mala Shanmugam United States 18 971 0.9× 511 0.6× 389 1.4× 75 0.5× 86 0.6× 42 1.4k
Shanmugasundaram Ganapathy‐Kanniappan United States 20 1.4k 1.4× 1.2k 1.5× 321 1.1× 188 1.2× 112 0.8× 36 2.2k
Wenxia Xu China 26 1.3k 1.3× 795 1.0× 349 1.2× 136 0.8× 86 0.6× 74 1.8k

Countries citing papers authored by Mark A. Keibler

Since Specialization
Citations

This map shows the geographic impact of Mark A. Keibler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Keibler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Keibler more than expected).

Fields of papers citing papers by Mark A. Keibler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Keibler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Keibler. The network helps show where Mark A. Keibler may publish in the future.

Co-authorship network of co-authors of Mark A. Keibler

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Keibler. A scholar is included among the top collaborators of Mark A. Keibler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Keibler. Mark A. Keibler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Keibler, Mark A., Gautham Sridharan, Marianne T. Sweetser, & Simina Ticau. (2024). Elevated homocysteine is negatively correlated with plasma cystathionine β‐synthase activity in givosiran‐treated patients. JIMD Reports. 65(4). 262–271.
2.
Keibler, Mark A., Wentao Dong, Jenny Ghelfi, et al.. (2023). Stable Isotope-Assisted Untargeted Metabolomics Identifies ALDH1A1-Driven Erythronate Accumulation in Lung Cancer Cells. Biomedicines. 11(10). 2842–2842. 1 indexed citations
3.
Noetzli, Leila, Anna Borodovsky, Justin Darcy, et al.. (2023). 830-P: Preclinical Development of ALN-KHK, an Investigational RNAi Therapeutic for Type 2 Diabetes Mellitus. Diabetes. 72(Supplement_1). 1 indexed citations
4.
Keibler, Mark A., Wentao Dong, Keegan Korthauer, et al.. (2021). Differential substrate use in EGF‐ and oncogenic KRAS‐stimulated human mammary epithelial cells. FEBS Journal. 288(19). 5629–5649. 3 indexed citations
5.
Wang, Haizhen, Brandon Nicolay, Joel M. Chick, et al.. (2017). The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival. Nature. 546(7658). 426–430. 263 indexed citations
6.
Hung, Yin P., Carolyn Teragawa, Taryn E. Gillies, et al.. (2017). Akt regulation of glycolysis mediates bioenergetic stability in epithelial cells. eLife. 6. 56 indexed citations
7.
Dong, Wentao, Mark A. Keibler, & Gregory Stephanopoulos. (2017). Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis. Metabolic Engineering. 43(Pt B). 113–124. 54 indexed citations
8.
Berrios, Christian, Megha Padi, Mark A. Keibler, et al.. (2016). Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation. PLoS Pathogens. 12(11). e1006020–e1006020. 63 indexed citations
9.
Keibler, Mark A., Thomas M. Wasylenko, Joanne K. Kelleher, et al.. (2016). Metabolic requirements for cancer cell proliferation. Cancer & Metabolism. 4(1). 16–16. 104 indexed citations
10.
Papagiannakopoulos, Thales, Benjamin A. Olenchock, Julia E. Heyman, et al.. (2016). Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer. Cell Metabolism. 23(3). 517–528. 554 indexed citations breakdown →
11.
Zhang, Jie, Woo Suk Ahn, Paulo A. Gameiro, et al.. (2014). 13C Isotope-Assisted Methods for Quantifying Glutamine Metabolism in Cancer Cells. Methods in enzymology on CD-ROM/Methods in enzymology. 542. 369–389. 40 indexed citations
12.
Fendt, Sarah‐Maria, Eric L. Bell, Mark A. Keibler, et al.. (2013). Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism. Cancer Research. 73(14). 4429–4438. 7 indexed citations
13.
Fendt, Sarah‐Maria, Eric L. Bell, Mark A. Keibler, et al.. (2013). Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells. Nature Communications. 4(1). 2236–2236. 274 indexed citations
14.
Dowling, Matthew B., et al.. (2011). A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action. Biomaterials. 32(13). 3351–3357. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026